文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

与普通人群相比,老年 ICU 患者的长期条件死亡率。

The long-term conditional mortality rate in older ICU patients compared to the general population.

机构信息

Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

出版信息

Crit Care. 2024 Nov 14;28(1):368. doi: 10.1186/s13054-024-05147-z.


DOI:10.1186/s13054-024-05147-z
PMID:39543756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11566578/
Abstract

BACKGROUND: Understanding how preexisting comorbidities may interact with a critical illness is important for the assessment of long-term survival probability of older patients admitted to the ICU. MATERIAL AND METHODS: The mortality after a first ICU admission in patients ≥ 55 years old registered in the Swedish Intensive Care Registry was compared to age- and sex-matched individuals from the general population with a landmark after 1 year. The comparison was adjusted for age, sex, and baseline comorbidity using Cox regression. RESULTS: The 7-year study period included 140 008 patients, of whom 23% were 80 years or older. Patients surviving the first year remained at an increased risk compared to the general population, but much of this difference was attenuated after adjustment for baseline comorbidity (HR, 1.03; 95% CI 1.02-1.04). Excluding cardio-thoracic ICU admissions, the increased risk remained slightly elevated (adjusted HR, 1.15; 95% CI 1.13-1.16). Also, the subgroup ≥ 75 years old surviving the first year returned to a mortality rate comparable to the general population (HR, 0.98; 95% CI 0.96-0.99). Stratified by admission diagnosis an increased mortality rate remained beyond the first year for acute-on-chronic respiratory failure (adjusted HR, 1.47; 95% CI 1.36-1.58) but not for other respiratory causes (adjusted HR, 1.03; 95% CI 0.99-1.07) or admission for septic shock (adjusted HR, 1.04; 95% CI 0.95-1.13). No substantial increased mortality rate was notable beyond the first year for other admission diagnoses. CONCLUSION: Older ICU patients that survive the first year after an ICU admission return to a mortality rate close to that of the general population having similar baseline comorbidity, but variability is seen depending on the ICU admission diagnosis. Trial registration ClinicalTrials.gov ID: NCT06234709, date 02/01/2024.

摘要

背景:了解预先存在的合并症如何与危重病相互作用,对于评估 ICU 收治的老年患者的长期生存概率很重要。

材料和方法:在瑞典重症监护登记处登记的≥55 岁的患者首次 ICU 入院后的死亡率与年龄和性别匹配的普通人群进行了比较,以 1 年为标志。使用 Cox 回归比较,调整年龄、性别和基线合并症。

结果:7 年的研究期间包括 140008 名患者,其中 23%为 80 岁或以上。与普通人群相比,存活至第 1 年的患者仍然存在风险增加,但在调整基线合并症后,这种差异大部分减弱(HR,1.03;95%CI,1.02-1.04)。不包括心胸 ICU 入院,风险略有升高(调整 HR,1.15;95%CI,1.13-1.16)。此外,≥75 岁且存活至第 1 年的亚组患者的死亡率恢复到与普通人群相当的水平(HR,0.98;95%CI,0.96-0.99)。按入院诊断分层,急性加重慢性呼吸衰竭(调整 HR,1.47;95%CI,1.36-1.58)的死亡率在第 1 年后仍持续升高,但其他呼吸原因(调整 HR,1.03;95%CI,0.99-1.07)或脓毒症性休克(调整 HR,1.04;95%CI,0.95-1.13)的死亡率无明显升高。对于其他入院诊断,第 1 年后死亡率没有明显升高。

结论:在 ICU 收治后存活第 1 年的老年 ICU 患者的死亡率恢复到接近普通人群的水平,同时存在类似的基线合并症,但根据 ICU 入院诊断,存在一定的变异性。

试验注册:ClinicalTrials.gov ID:NCT06234709,日期 2024 年 2 月 1 日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f220/11566578/8b009155e2fd/13054_2024_5147_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f220/11566578/6dceed4fd90c/13054_2024_5147_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f220/11566578/bf21325b2e2e/13054_2024_5147_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f220/11566578/83fda1102c36/13054_2024_5147_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f220/11566578/8b009155e2fd/13054_2024_5147_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f220/11566578/6dceed4fd90c/13054_2024_5147_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f220/11566578/bf21325b2e2e/13054_2024_5147_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f220/11566578/83fda1102c36/13054_2024_5147_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f220/11566578/8b009155e2fd/13054_2024_5147_Fig4_HTML.jpg

相似文献

[1]
The long-term conditional mortality rate in older ICU patients compared to the general population.

Crit Care. 2024-11-14

[2]
Early versus late tracheostomy in people with multiple trauma.

Cochrane Database Syst Rev. 2025-8-6

[3]
Three-year mortality of ICU survivors with sepsis, an infection or an inflammatory illness: an individually matched cohort study of ICU patients in the Netherlands from 2007 to 2019.

Crit Care. 2024-11-19

[4]
Epidemiology and outcomes of septic shock in Japan: a nationwide retrospective cohort study from a medical claims database by the Japan Sepsis Alliance (JaSA) study group.

Crit Care. 2025-7-16

[5]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[6]
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.

Syst Rev. 2024-11-26

[7]
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.

Clin Orthop Relat Res. 2024-12-1

[8]
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Health Technol Assess. 2007-11

[9]
Impact of frailty on in-hospital outcomes in nonagenarian ICU patients: a binational multicenter analysis of 8,220 cases.

Crit Care. 2025-8-27

[10]
Interventions for preventing critical illness polyneuropathy and critical illness myopathy.

Cochrane Database Syst Rev. 2014-1-30

引用本文的文献

[1]
Prognostic analysis of elderly patients with pathogenic microorganisms positive for sepsis-associated encephalopathy.

Front Microbiol. 2024-12-16

本文引用的文献

[1]
Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial.

J Clin Epidemiol. 2024-10

[2]
Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST): a prospective, multi-centre, cohort study.

Intensive Care Med. 2024-7

[3]
Exploring the Impact of Age, Frailty, and Multimorbidity on the Effect of ICU Interventions: A Systematic Review of Randomized Controlled Trials.

Crit Care Med. 2024-9-1

[4]
Comorbidity influence in observational studies: Why ignore the real world?

Pharmacoepidemiol Drug Saf. 2024-4

[5]
The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years.

Ann Intensive Care. 2024-3-30

[6]
Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study.

PLoS One. 2024

[7]
Optimized diagnosis-based comorbidity measures for all-cause mortality prediction in a national population-based ICU population.

Crit Care. 2022-10-6

[8]
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.

Eur Heart J. 2022-10-14

[9]
A new multi-national network studying Very old Intensive care Patients (VIPs).

Anaesthesiol Intensive Ther. 2021

[10]
Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.

PLoS One. 2021

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索